ChemoFx Pro, a Post-Market Data Collection Study of Physician Reported Outcomes

StatusFinished
Effective start/end date21/02/11 → 31/03/15

Funding

  • Precision Therapeutics: $5,412.50
View all
View less

Keywords

  • Biotechnology & Drug Development, Cancer Research